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InterPro amalgamates predictive protein signatures from a number of well-known partner databases into a single resource.
To aid with interpretation of results, InterPro entries are manually annotated with terms from the Gene Ontology (GO). The
InterPro2GO mappings are comprised of the cross-references between these two resources and are the largest source of GO
annotation predictions for proteins. Here, we describe the protocol by which InterPro curators integrate GO terms into the
InterPro database. We discuss the unique challenges involved in integrating specific GO terms with entries that may
describe a diverse set of proteins, and we illustrate, with examples, how InterPro hierarchies reflect GO terms of increasing
specificity. We describe a revised protocol for GO mapping that enables us to assign GO terms to domains based on the
function of the individual domain, rather than the function of the families in which the domain is found. We also discuss
how taxonomic constraints are dealt with and those cases where we are unable to add any appropriate GO terms. Expert
manual annotation of InterPro entries with GO terms enables users to infer function, process or subcellular information for
uncharacterized sequences based on sequence matches to predictive models.
Database URL: http://www.ebi.ac.uk/interpro. The complete InterPro2GO mappings are available at: ftp://ftp.ebi.ac.uk/pub/
databases/GO/goa/external2go/interpro2go
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Introduction
The InterPro database (1) is an integrated resource of pre-
dictive protein signatures. These signatures use a range
of computational methods to infer potential structure,
function and/or evolutionary relationships for a query
sequence. Equivalent signatures are grouped together in
the same InterPro entry, and each entry contains informa-
tion about the proteins matched by these signatures,
including manual annotation, and links to related resources
to provide enhanced biological context. Each InterPro
entry is assigned a type depending on what the entry de-
scribes: family (a group of proteins with a common evolu-
tionary origin), domain (a distinct functional, structural or
sequence unit), site (which may be further subdivided into
active site, binding site, conserved site or post-translational
modification) and repeat (full definitions of InterPro entry
types are via the user documentation available at: http://
www.ebi.ac.uk/interpro/). A protein sequence may match
several InterPro entries; for example, it may have matches
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well as to entries describing the protein family to which
it belongs. Some InterPro entries are also organized in hier-
archies, which are used to link more general entries
(termed the parent entry) to more specific entries
(known as child entries). The database is searchable by a
range of identifiers, or by sequence using InterProScan (2).
InterPro data are frequently used by genome/proteome
sequencing projects to assist in characterization of putative
gene products (3), and are widely included in pipelines for
annotation of sequences from next-generation sequencing
efforts (4).
The Gene Ontology (GO) Consortium provides a con-
trolled vocabulary that can be used to describe gene prod-
ucts in a consistent and structured fashion (5). The GO is the
most widely used biomedical ontology and the utility of GO
annotations is highlighted by the number of resources that
provide them, including major sequence databases [such as
UniProtKB (6)] and many of the prominent model organism
databases (7). The GO consists of three structured ontolo-
gies, describing Molecular Function, Biological Process and
Cellular Component. Terms are related to each other by
well-defined relationships, and are provided with stable,
unique identifiers and explicit, consistent descriptions.
GO terms are assigned to genes or gene product identifiers
by biological database annotation efforts by manually
extracting evidence from published experimental data,
inferring annotations based on homology or via a range
of computational inference methods. The nature of the
evidence used to assign a GO term to a given protein is
indicated by an evidence code.
Manual annotation of individual gene product se-
quences from the literature provides the gold standard
of functional annotation, but it is a time-consuming ap-
proach. The rapidly increasing amount of sequence data
for diverse organisms means that automated annotation
plays an essential role in predicting gene product behav-
iour. InterPro’s aim is to provide high-quality automat-
ic annotation, based on experimental evidence. GO
annotation provided by InterPro is the largest source of
automatic GO annotation for proteins from all organisms,
(e.g. as of UniProtKB-GOA v101, it supplies 66% of the GO
annotations for UniProtKB proteins, providing over 56 mil-
lion distinct annotations) and is used by many annotation
communities to supplement their manual annotation work.
Importantly, InterPro GO annotation allows users to infer
information about an uncharacterized sequence based on
match(es) of that sequence to a GO-annotated InterPro
entry. This process enables transfer of information from
evolutionarily related sequences that have been character-
ized experimentally. InterPro has been producing GO anno-
tations since 2002, and the InterPro approach to GO
annotation, its benefits and limitations are described in
this article.
Methods
GO terms are assigned to the InterPro entry, not to the
individual sequence
A cornerstone of the InterPro GO annotation protocol is
that curators annotate an InterPro entry, and not to the
individual sequence; this is the key difference between
InterPro GO annotations and those provided by manual an-
notation efforts. GO terms are assigned by a curator to an
InterPro entry based on the common characteristics of the
protein set matched by the signatures belonging to that
entry. InterPro2GO annotations all apply the GO evidence
code ‘Inferred from Electronic Annotation’ (IEA), indicating
that the GO annotations are the result of an automated
prediction pipeline and have not been individually
reviewed by curators. An individual sequence will therefore
inherit an InterPro GO term if it matches the signatures
within the InterPro entry when searched against them.
GO terms assigned to InterPro entries must apply to
the majority of proteins in the entry
InterPro entries annotate all sequences that match the com-
putational signature(s) contained in the entry; entries may
contain signatures describing a small set of proteins with
high-functional specificity (as in the case of IPR004025:
fungal ribotoxin that matches 34 proteins), or they may
contain signatures describing a large and functionally di-
verse family (as in the case of IPR011701: major facilitator
superfamily that matches 108611 proteins). It is only pos-
sible to transfer GO annotations from the UniProtKB record
of a protein if those terms are considered to be applicable
to all the other sequences associated with the entry. Large
and diverse families may contain proteins with many anno-
tations that are too specific to apply to the entire InterPro
entry.
General protocol
A flowchart illustrating the InterPro curator protocol is pre-
sented in Figure 1. When annotating an InterPro entry, a
curator first identifies those UniProtKB/Swiss-Prot (i.e. re-
viewed) sequences matched by the entry that has been ex-
perimentally characterized. Based on this information, the
curator considers whether each of the GO terms that could
potentially be applied is valid for the remaining proteins in
the match set. This is done by evaluating alignments of the
sequences and the experimental evidence in the literature.
The UniProtKB/Swiss-Prot GO terms should be applicable to
at least 95% of reviewed proteins in the entry. This cut-off
sets a stringent standard for evidence yet provides enough
flexibility to accommodate the predictive nature of the sig-
natures used in creating InterPro entries. More stringent
requirements would result in a loss of a large number of
valid InterPro2GO mappings. InterPro GO coverage as of
InterPro v34.0 is detailed in Table 1.
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be attached to an entire InterPro entry, the InterPro curator
can choose a related but more general GO term that is
nonetheless still applicable to the full set of sequences. If
no GO term exists to describe the function, creation of an
appropriate term is requested from the GO consortium. If
there is no experimental evidence to confirm a function,
process or location term that can be applied to all se-
quences in the entry, then no GO term is applied.
While UniProtKB/Swiss-Prot annotations are used as a
starting point, we are not limited to these terms: unre-
viewed proteins in UniProtKB/TrEMBL are included for con-
sideration if there is sufficient experimental evidence in
support of a particular GO term. Similarly, if a curator iden-
tifies a function, process or location in the literature, which
is applicable to the entire InterPro entry protein match set
but which is not currently annotated to any individual se-
quence by UniProtKB, the appropriate term is added to the
entry. GO annotations by TIGRFAMs (8), HAMAP (9) and
PANTHER keywords (10) are also considered for annotation,
and are reviewed by a curator before inclusion. Once GO
terms have been chosen, the InterPro abstract is updated
with references to the literature supporting the annota-
tion. With the exception of conserved sites (where there
is an implicit lack of experimental evidence detailing
InterPro Entry sequence 
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experimental evidence
Curator checks TrEMBLs
for experimental evidence
No GO term applied
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GO terms 
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SwissProts?
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possible GO term
Experimental 
evidence?
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to entry 
Figure 1. Flowchart outlining the decision process taken by InterPro curators in order to assign GO terms.
Table 1. InterPro GO annotation coverage as of InterPro v34
InterPro2GO, v 34.0 Entries Coverage (%)
Number of InterPro entries 22245 100
Associated with at least one
GO term
10721 46.2
Unmapped entries 11974 54.8
Of which conserved sites 634 2.9
Other unmappable entries 3335 15.0
Number of unique GO terms 3568
Number of individual sequences
annotated
11515689
.............................................................................................................................................................................................................................................................................................
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protocol currently applies to all InterPro entry types; how-
ever, some changes (detailed below) now occur for
domains.
InterPro GO annotations are available to the community
primarily in two forms: users may query a sequence or se-
quences using InterProScan, or browse and download map-
pings at the InterPro website. InterPro GO annotations are
also available at a sequence level via UniProt-GOA.
InterPro and GO data structures are complementary
More specific family or domain entries, located at the leaf
nodes of InterPro hierarchies (and which therefore might
only describe a few well-characterized proteins) may be
annotated with a correspondingly specific GO term.
Conversely, more general InterPro family and domain
entries may be annotated with a more general GO term,
subject to meeting evidence requirements.
In Figure 2, we present an example of InterPro GO map-
ping, as applied to family entries, which illustrates the re-
quirement for evidence and the complementary nature of
the InterPro and GO data structures. The InterPro entry
‘Glycosyl transferase, family 9’ (IPR002201) is mapped to
the molecular function term ‘transferase activity, transfer-
ring glycosyl groups’ (GO:0016757), while its child entry
‘Lipopolysaccharide heptosyltransferase I’ (IPR011908) is
annotated with the more specific ‘Lipopolysaccharide
heptosyltransferase activity’ (GO:0008920). However,
another child entry of the ‘Glycosyl transferase, family 9’
represents ‘Lipopolysaccharide heptosyltransferase III, puta-
tive’ (IPR011916) and has not been assigned more specific
GO annotation because although the signature does match
reviewed proteins, no experimental evidence is available in
the literature to support their function.
Improved GO annotation of InterPro domain entries
Historically, InterPro entries of type domain were assigned
GO terms from the protein families in which the domain
was found, and not based on the function of the specific
domain that the entry describes (11). This potentially could
lead to the domain being incorrectly annotated with the
function of another domain with which it co-occurs in a
given protein family. Henceforth, GO terms will be applied
to domains according to published experimental evidence
of the domain’s specific function. Otherwise, the curation
procedure is identical to that outlined in the general
protocol.
Quality control
The predictive nature of the signatures contained within
InterPro means that inappropriate matches (false positives)
to InterPro signatures occasionally occur. A protein that has
obtained an incorrect GO annotation by virtue of a false
positive match to an InterPro entry (so long as that InterPro
Figure 2. Application of GO molecular function terms to IPR002201 and its child entries. IPR002201 is a more general entry,
which encompasses the proteins matched by its three child entries, IPR011908, IPR011910 and IPR011916. The increased specificity
of the child entry can be reflected in the GO annotation; IPR011908 has a more specific Molecular Function term than the parent
entry IPR002201.
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UniProtKB-GOA (12). The InterPro GO annotation for that
individual sequence may then be annotated with a NOT
qualifier, and this information made available at the
UniProtKB-GOA webpage for the sequence.
Additionally, some GO terms have taxonomic constraints,
i.e. they may only be applied to proteins belonging to cer-
tain taxonomic groups (13). These taxonomic restrictions
are a GO resource and are used in collaboration with the
UniProtKB-GOA annotation project. The taxonomic con-
straints developed by the GO Consortium are broadly
defined as two types: only_in and never_in. The only_in
constraint means that a given GO term may only be applied
to gene products from the specified taxonomic grouping,
while the never_in constraint means that the GO term
must not be applied to gene products from the specified
taxonomic groups. Prior to each release, InterPro GO
terms that violate these constraints are checked for.
We also check automatically for redundant terms, such as
cases where two GO terms with the same path to the
root term have been applied to a single entry. Terms
appearing in these automatic checks are referred for
manual curation.
Given the sheer volume of sequence space that InterPro
covers, we rely heavily on communications from our users
to alert us to incorrect individual GO mappings. Users who
identify incorrect mappings or wish to suggest possible GO
terms may notify InterPro curators through the support
channels on the InterPro website. Feedback from users
who have identified GO terms that are incorrect or too
specific enables constant refinement of the mappings.
p53 as a case study of InterPro GO annotation
The p53 family of tumour suppressors is well studied due to
its central role in human diseases. In mammals, p53 drives
the transactivation of apoptosis-inducing genes and there-
fore plays a key role in triggering appropriate cell death
based on injury or other cell insult (14). Proteins in the p53
family consist of a DNA-binding domain and a tetrameriza-
tion domain; family members also have a transactivation
domain, however, there are N isoforms that lack transac-
tivation activity (15). Furthermore, in p63 and p73 family
members, a large number of C-terminal splice variants exist
that add considerable functional and structural diversity. In
Figure 3, we have used the tumour suppressor p53 family of
proteins to illustrate GO annotation within InterPro. Note
that all accessions and protein counts used in this example
are referring to release 34.0 of InterPro.
The most specific family entry containing the Homo
sapiens p53 tumour suppressor (UniProtKB accession:
P04637) is ‘p53 tumour suppressor family’ (IPR002117),
containing 331 proteins. This entry covers several different
isoforms of p53, p63 and p73. Due to its role as a tran-
scriptional activator, the p53 family has GO terms attached
to it that describe various aspects of this process: ‘regulation
of transcription, DNA dependent’ (GO:0006355), ‘DNA bind-
ing’ (GO:0003677), ‘sequence-specific DNA binding transcrip-
tion factor activity’ (GO:0003700), ‘apoptosis’ (GO:0006915)
and ‘nucleus’ (GO:0005634). As the InterPro entry describes
both N and TA isoforms, we are unable to apply the more
specific ‘positive regulation of apoptosis’ (GO:0043065) or
‘negative regulation of apoptosis’ (GO:0043066), as applica-
tion of these terms would be incorrect for a significant
Figure 3. Complementary domain and family GO mapping for InterPro entries that match the human cellular tumour antigen
p53. Domain GO annotation enables the function(s) of the family to be attributed to individual domains within the protein.
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previously described 95% guideline.
The three InterPro domains matching p53 provide GO
annotation that is complementary to the family annota-
tion. The p53 transactivation domain represented by
IPR013872 is currently only mapped to the ‘protein binding’
(GO:0005515) term as there is currently no GO term that
adequately covers the role this domain plays in binding
co-activators such as p300. The p53 DNA-binding domain
(IPR011615) is mapped to ‘transcription regulatory region
DNA binding’ (GO:0044212). Under the new domain map-
ping guidelines, it would not be mapped to (for example)
‘sequence-specific DNA binding transcription factor activity’
(GO:0003700), as this behaviour is only exhibited by the
whole protein, and is not solely due to this domain acting
independently. Finally, the p53 C-terminal tetramerization
domain (IPR010991) is mapped to ‘protein tetramerization’
(GO:0051262). By combining GO annotations from domain
and family entries that a protein matches, users can identify
which domains are responsible for particular elements of
protein family function. This example illustrates how a
domain-based approach to GO mapping leads to a more
accurate and useful association of GO terms to proteins.
Summary
Increasing volumes of genomic and meta-genomic data
from high-throughput sequencing technologies means
that annotation of gene products remains a bottleneck,
and that automated methods are increasingly important
for our interpretation of this wealth of data. InterPro GO
annotations provide a valuable means of annotating
sequences about which little is known experimentally,
based as far as possible on experimental evidence of hom-
ologous sequences. The InterPro2GO mappings produce
high-quality GO annotations to individual sequences that
are based on a combination of experimental evidence and
sequence analysis. We aim to give InterPro’s data a func-
tional, structural and evolutionary context to ensure its
continued utility to the biological community and the GO
annotation process is crucial to achieving this aim.
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